Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations

Alan L. Ho^*, Irene Brana, Robert Haddad, Jessica Bauman, Keith Bible, Sjoukje Oosting, Deborah J. Wong, Myung Ju Ahn, Valentina Boni, Caroline Even, Jerome Fayette, Maria José Flor, Kevin Harrington, Sung Bae Kim, Lisa Licitra, Ioanna Nixon, Nabil F. Saba, Stephan Hackenberg, Pol Specenier, Francis WordenBinaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

133 Citations (Scopus)

29 Downloads (Pure)

133 Citations
1 Correction

1 results

Filter

2021
Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)
Ho, A. L., Brana, I., Haddad, R., Bauman, J., Bible, K., Oosting, S., Wong, D. J., Ahn, M. J., Boni, V., Even, C., Fayette, J., Flor, M. J., Harrington, K., Kim, S. B., Licitra, L., Nixon, I., Saba, N. F., Hackenberg, S., Specenier, P. & Worden, F. & 5 others, Balsara, B., Leoni, M., Martell, B., Scholz, C. & Gualberto, A., 1 Oct 2021, In: Journal of Clinical Oncology. 39, 28, p. 3192-3193 2 p.
Research output: Contribution to journal › Correction › peer-review

Open Access

Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations

Research output

Search results

Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)